London – M42, a global health leader powered by artificial intelligence (AI), and Hikma Pharmaceuticals PLC (Hikma), ...

The Achievers University, Owo, Ondo State has warned new students of the institution against involving in acts that could ...

The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and ...

If you are pregnant or nursing, talk with your health care professional about whether to enroll in pregnancy safety or ...

With this step, DGFT is enhancing ease of doing business for pharmaceutical exporters while ensuring regulatory coherence. Accordingly, the provisions under Para 2.76 of the Handbook of Procedures ...

The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the ...

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...

The Inflation Reduction Act (IRA) significantly changed the popular Medicare drug programs. While an IRA policy goal is to reduce the ...